These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6280931)

  • 1. Pharmacokinetics of a new cephalosporin, cefotaxime (HR 756) in patients with different renal functions.
    Bergan T; Larsen EW; Brodwall EK
    Chemotherapy; 1982; 28(2):85-104. PubMed ID: 6280931
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacokinetics of cefotaxime and ceftriaxone in renal and hepatic dysfunction.
    Wise R; Wright N
    Infection; 1985; 13 Suppl 1():S145-50. PubMed ID: 4055047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic interactions between azlocillin, cefotaxime, and cefotaxime metabolites in normal and impaired renal function.
    Kampf D; Borner K; Möller M; Kessel M
    Clin Pharmacol Ther; 1984 Feb; 35(2):214-20. PubMed ID: 6319069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of cefotaxime and metabolites in uremic patients (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Godin M; Humbert G
    Nephrologie; 1982; 3(1):12-8. PubMed ID: 6283411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination kinetics of cefotaxime and desacetyl cefotaxime in patients with renal insufficiency and during hemodialysis.
    Ohkawa M; Okasho A; Motoi I; Tokunaga S; Shoda R; Kawaguchi S; Sawaki M; Shimamura M; Hirano S; Kuroda K; Awazu S
    Chemotherapy; 1983; 29(1):4-12. PubMed ID: 6299656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doses of antibiotic in patients with renal insufficiency.
    Ohkawa M; Kuroda K
    Clin Ther; 1981; 4 Suppl A():124-32. PubMed ID: 6275994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of cefotaxime and its metabolites in subjects with normal and impaired renal function.
    Ings RM; Fillastre JP; Godin M; Leroy A; Humbert G
    Rev Infect Dis; 1982; 4 Suppl():S379-91. PubMed ID: 6294787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftizoxime kinetics and renal handling.
    Dubb J; Actor P; Pitkin D; Alexander F; Familiar R; Ehrlich S; Stote R
    Clin Pharmacol Ther; 1982 Apr; 31(4):516-21. PubMed ID: 6277546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of cefotaxime in patients with normal and reduced renal function.
    Doluisio JT
    Rev Infect Dis; 1982; 4 Suppl():S333-45. PubMed ID: 6294782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics and tissue penetration of ceftriaxone].
    Bergan T
    Rev Med Interne; 1985 Mar; 6(2):163-77. PubMed ID: 3890053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of vinpocetine and apovincaminic acid in patients with impaired renal function.
    Miskolczi P; Vereczkey L; Szalay L; Göndöcs CS
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):169-75. PubMed ID: 6745306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of Cefmenoxime in normal and impaired renal function.
    Höffler D; Koeppe P
    Arzneimittelforschung; 1983; 33(2):269-72. PubMed ID: 6303362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefotaxime after a single intravenous dose in patients with impaired renal function.
    Moukhtar I; Nawishy S; Sabbour M
    Chemioterapia; 1987 Feb; 6(1):38-40. PubMed ID: 3829135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose ceftriaxone kinetics in functionally anephric patients.
    Stoeckel K; McNamara PJ; Hoppe-Seyler G; Blumberg A; Keller E
    Clin Pharmacol Ther; 1983 May; 33(5):633-41. PubMed ID: 6301740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cefotaxime and probenecid in sheep with normal and reduced renal function.
    Guerrini VH; Filippich LJ; English PB; Cao GR; Bourne DW
    J Vet Pharmacol Ther; 1984 Dec; 7(4):283-91. PubMed ID: 6096576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosage of chemotherapeutic agents in patients with renal disease.
    Dettli L
    Prog Clin Biol Res; 1979; 35():141-6. PubMed ID: 538028
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftazidime in patients with impaired renal function. Studies on pharmacokinetics and nephrotoxicity.
    Thurmann-Nielsen E; Walstad RA; Dahl K; Hellum KB
    J Chemother; 1989 Jul; 1(4 Suppl):534-5. PubMed ID: 16312519
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in cirrhosis of the liver.
    Höffken G; Lode H; Koeppe P; Ruhnke M; Borner K
    Chemotherapy; 1984; 30(1):7-17. PubMed ID: 6319092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefotaxime in sheep.
    Guerrini VH; Filippich L; English PB; Bourne DW
    Am J Vet Res; 1983 Aug; 44(8):1488-91. PubMed ID: 6312852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.